Eli Lilly invites you to an informative discussion on the evolving management of psoriasis, featuring leading dermatologist Dr. Rajiv Sekhri. The discussion will explore the burden of psoriasis, available therapeutic options and key challenges in disease management, along with the evolution of treatment targets and the efficacy and safety profile of ixekizumab. The discussion will also address frequently asked questions on ixekizumab and feature an interactive Q&A, offering an opportunity to engage with the expert and clarify clinical queries. Join us on 23 September 2026 , from 8:00 PM to 9:00 PM IST , to gain practical insights that can support your approach to psoriasis management.

We look forward to your participation. Agenda : Click here to view Copellor API . This content is approved by Eli Lilly and Company (“Lilly”). This content is the intellectual property of Lilly and its…